Understanding Migraines: Triggers, Symptoms, Treatment, and Prevention

What Is Migraine?

A complex neurovascular disorder characterized by recurrent attacks of moderate-to-severe headache, typically unilateral and throbbing, aggravated by routine activity, and accompanied by nausea, photophobia, and phonophobia. Affects ~12% of the population (3:1 female-to-male ratio).

Attack Phases

  1. Prodrome (hours to days before): Mood changes, fatigue, yawning, food cravings, neck stiffness.
  2. Aura (25% of patients, 5–60 minutes): Visual (scotoma, fortification spectra), sensory, speech, or motor disturbances.
  3. Headache (4–72 hours): Throbbing, unilateral, with nausea/vomiting, light and sound sensitivity.
  4. Postdrome ("hangover"): Fatigue, cognitive fog, residual sensitivity.

Common Triggers (Highly Individualized)

  • Dietary: Aged cheese, cured meats, alcohol (especially red wine), caffeine withdrawal, aspartame, MSG, dehydration.
  • Hormonal: Menstrual cycle (estrogen drop), oral contraceptives, perimenopause.
  • Environmental: Weather changes, bright lights, strong odors, altitude.
  • Sleep: Too little, too much, or schedule shifts.
  • Stress: "Let-down" migraines after stress (e.g., weekends).
  • Physical: Exertion, sexual activity, head trauma.

Management Framework

Acute Treatment (At Onset)

  • Mild-moderate: NSAIDs (naproxen, ibuprofen), acetaminophen, combination analgesics.
  • Moderate-severe or NSAID failure: Triptans (sumatriptan, rizatriptan, eletriptan)—7 agents, various routes.
  • Newer agents: Gepants (ubrogepant, rimegepant), ditans (lasmiditan)—no vascular contraindications.
  • Anti-emetics: Metoclopramide, prochlorperazine (IV in ER).
  • Rescue: NSAID + triptan + antiemetic combination.

Preventive Treatment (If ≥4 headache days/month or disabling)

  • Oral: Beta-blockers (propranolol), topiramate, valproate, candesartan, amitriptyline.
  • Injectable CGRP monoclonal antibodies: Erenumab, fremanezumab, galcanezumab, eptinezumab (quarterly IV)—transformative for many.
  • Oral CGRP antagonists: Atogepant, rimegepant (dual acute/preventive).
  • Botox: Chronic migraine (≥15 headache days/month)—31-site injection every 12 weeks.
  • Devices: Nerivio (remote electrical neuromodulation), gammaCore (non-invasive vagus nerve stimulation), Cefaly (transcutaneous VNS).

Lifestyle Foundation (SEEDS)

  • Sleep: Consistent schedule, 7–9 hours.
  • Exercise: 150 min/week moderate aerobic.
  • Eat: Regular meals, hydration, trigger avoidance.
  • Diary: Track triggers, patterns, treatment response.
  • Stress management: CBT, biofeedback, mindfulness, relaxation training.

Red Flags (Secondary Headache Workup Needed)

  • Thunderclap onset ("worst ever")
  • New headache >50, or pattern change
  • Focal neurologic signs, papilledema
  • Systemic symptoms (fever, weight loss)
  • Post-traumatic, positional, exertional

Migraine is treatable. Partner with a headache specialist for a personalized plan.

Migraine - Related Articles